Company
VivoSense
We are your complete Wearable Sensor CRO
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Founded
- 2010
- Customers
- pharmaceutical sponsor, CRO, or digital health innovator
Claim, correct or request removal
Record updated 28 September 2026
About
Since 2010, VivoSense has been revolutionizing clinical trials by developing and deploying digital endpoints from wearable devices. Our team of experts and our proprietary cloud platform add value at every phase of a clinical trial. From trial design to sensor selection and operationalization, data capture, cleaning, and analysis, our deep scientific knowledge and extensive clinical trial experience have been instrumental in helping clinical researchers analyze and interpret wearable sensor data, thereby enhancing patient research and care.
Funding snapshot
- Total raised
- $27MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $25M2022-03-04
Funding rounds
- Round, 2022
- $25M2022-03-04, SEC form D sold, 2 investors
- Round, 2019
- $2M2019-05-23, SEC form D sold, 1 investor
Products
- Web
- proprietary DHT platform
Loading relationship preview